Sunday 23 December 2012

Adalimumab May Improve Quality Of Life For Patients Suffering From Hidradenitis Suppurativa - A Serious Skin Disease

Adalimumab may reduce inflammation and pain and improve quality of life for patients with hidradenitis suppurativa (HS). HS is a chronic skin disease that occurs deep in the skin around oil glands and hair follicles causing red, tender bumps that often enlarge, break open and drain foul-smelling pus. HS is associated with pain and scarring, and often is resistant to treatment. Researchers conducted a phase 2, randomized, placebo-controlled trial to evaluate the efficacy and safety of adalimumab, an anti-tumor necrosis factor-α antibody, in 154 patients with moderate to severe HS...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/cc_EGquzFbc/254223.php

medical rehab sport

No comments:

Post a Comment